Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
General Outlook
In simple terms, Global Cord Blood Corporation has 133.915 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.859% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.478%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.356%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.157% return, is a testament to Global Cord Blood Corporation's adeptness in optimizing resource deployment. Global Cord Blood Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.075%. Furthermore, the proficiency of Global Cord Blood Corporation in capital utilization is underscored by a remarkable 0.228% return on capital employed.
Stock Prices
Global Cord Blood Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.9876, while its low point bottomed out at $2.9876. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Global Cord Blood Corporation's stock market.
